MicroGenDX
Focus: MicroGenDX is a public-stage diagnostics company specializing in molecular diagnostics and DNA sequencing, with 51-200 employees based in Lubbock, TX. The company develops sequencing-based diagnostic solutions for specialized medical indications.
Profile data last refreshed 7h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
2
Should You Work at MicroGenDX?
AI assessmentMicroGenDX is a niche diagnostic play suitable for specialists seeking early-stage innovation in sequencing, but limited hiring and sparse clinical data raise questions about trajectory and career mobility.
Why Work Here
- Public company status provides equity upside and potential exit liquidity vs. private-stage peers
- Niche focus on molecular diagnostics positions the company in a high-growth segment with durable competitive moats
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Slowing
Jobs decreasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Antimicrobial Skin & Wound Cleanser
Acute WoundNext-Generation DNA Sequencing
Penile ImplantationClinical Trials (1)
Help build intelligence for MicroGenDX
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.